MATTHEW BUREAU: Open Payments
NPI 1225037211 · LEWISTON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 21 payments from 4 companies in 2025. Trend: 2023 $162 · 2024 $61 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $173 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: SKYRIZI, Zoryve, Sotyktu, RINVOQ, NEMLUVIO.
Industry payments across ME — which companies pay providers there.
